Codexis
CDXS
$2.66
Share price
0.38%
Change (1 day)
-32.14%
Change (1 year)
Categories
Codexis (CDXS) - P/B ratio
P/B ratio as of April 2024 : 2.16
According to Codexis
's latest financial reports the company has a price-to-book ratio of 2.16.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Codexis - P/B ratio (from 2010 to 2023)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2023-12-31 | 2.46 | 16.32% |
| 2022-12-31 | 2.11 | -82.87% |
| 2021-12-31 | 12.3 | 51.27% |
| 2020-12-31 | 8.16 | -8.57% |
| 2019-12-31 | 8.92 | -44.36% |
| 2018-12-31 | 16.0 | -2.5% |
| 2017-12-31 | 16.4 | 65.65% |
| 2016-12-31 | 9.93 | 33.1% |
| 2015-12-31 | 7.46 | 96.84% |
| 2014-12-31 | 3.79 | 192.76% |
| 2013-12-31 | 1.29 | 21.88% |
| 2012-12-31 | 1.06 | -42.76% |
| 2011-12-31 | 1.86 | -46.05% |
| 2010-12-31 | 3.44 | |
| 2009-12-31 | N/A | |
| 2008-12-31 | N/A |
P/B ratio for similar companies or competitors
| Company | P/B ratio | differencediff. | Country |
|---|---|---|---|
 Pfizer PFE | 1.61 | -25.39% | 🇺🇸 USA |
 Merck MRK | 8.83 | 308.99% | 🇺🇸 USA |
 Dupont De Nemours DD | 1.25 | -42.27% | 🇺🇸 USA |
 Balchem BCPC | 4.26 | 97.46% | 🇺🇸 USA |